Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have been given a consensus recommendation of “Hold” by the nine analysts that are presently covering the stock, Marketbeat.com ...

Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year End 2024 Financial ... by commercial launch activities in the United States, with products anticipated to be available ...

Alan H. Bryce, MD, discusses areas of need to help guide treatment decisions in the clinic for prostate cancer management.

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...

Florentine Holding Company (FHC), the Ft. Myers, FL based commercial real estate investment and development firm, whose CRE investment and development projects create growth and economic expansion ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The stock market is waiting on a follow through day. Miami's eMerge Americas conference may provide some surprise energy for ...

Executives mingled with North Carolina leaders in the city of Wilson to ceremonially break ground on Johnson & Johnson’s ...

Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...